| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 63.71 | 0.10 (+0.16%) | 59.08 - 68.05 | 9.9 million (Below Avg) |
Market data as of 4:01PM 05/16/12. Quotes are delayed by at least 15 min.
| Open | 63.79 |
|---|---|
| Previous Close | 63.61 |
| Day's Range | 63.45 - 63.93 |
| Market Cap | 175.0B |
| Avg Volume (10 Day) | 16.2M |
| Price/Earnings (Trailing 12 Mo.) | 17.4x |
| Earnings Per Share (Trailing 12 Mo.) | 3.65 |
| Dividend Yield | 0.61 (3.83%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment for Atrial Fibrillation
Business Wire - Friday 05/11/2012 8:00 AM ET
CORRECTING and REPLACING Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors
Business Wire - Thursday 05/10/2012 8:58 AM ET
Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization
Business Wire - Thursday 05/10/2012 7:00 AM ET
Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the World
Business Wire - Wednesday 05/09/2012 9:00 AM ET
Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision™ With Dr. Val Jones
PR Newswire - Tuesday 05/08/2012 7:17 AM ET
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
PR Newswire - Thursday 05/03/2012 4:21 AM ET
Johnson & Johnson to Participate in 2012 Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
PR Newswire - Wednesday 05/02/2012 4:16 PM ET
Johnson & Johnson Holds 2012 Annual Meeting of Shareholders
PR Newswire - Thursday 04/26/2012 10:48 AM ET
| JNJ | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 4.61% | |
| Net Income Growth (1yr) | -17.73% | |
| Total Debt/Equity | 0.32 | |
| LT Debt/Equity | 0.21 | |
| Earnings Yield | 5.75% | |
| Price/Sales | 2.69 |
| Company | Last | Change |
|---|---|---|
| Pfizer Inc | 22.64 | +1.52% |
| Novartis AG | 52.10 | -0.36% |
| GlaxoSmithKline PLC | 45.37 | -0.22% |
| Merck & Co Inc | 38.23 | +1.30% |
| Abbott Laboratories | 62.55 | +1.07% |
Data is delayed by at least 15 min.